Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy

Ishikura, Kenji; Matsumoto, Shinsuke; Sako, Mayumi; Tsuruga, Kazushi; Nakanishi, Koichi; Kamei, Koichi; Saito, Hiroshi; Fujinaga, Shuichiro; Hamasaki, Yuko; Chikamoto, Hiroko; Ohtsuka, Yasufumi; Komatsu, Yasuhiro; Ohta, Toshiyuki; Nagai, Takuhito; Kono, Hiroshi; Kondo, Shuji; Ikezumi, Yohei; Tanaka, Seiji; Kaku, Yoshitsugu; Iijima, Kazumoto

doi:10.1007/s10157-014-1030-x

Cited by 79 publications

(62 citation statements)

References 164 publications

(255 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…SRNS was diagnosed if complete remission was not achieved after treatment with 2 mg/kg prednisolone daily for 4 weeks [8]. Complete remission was defined as negative or trace proteinuria (by the dipstick method or a urinary protein/creatinine ratio of ≤0.20 mg/mg) on urinalysis and a serum albumin level of>2.5 g/dl.…”

Section: Definitionsmentioning

confidence: 99%

Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in children

et al. 2015

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Definitionsmentioning

confidence: 99%

Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in children

et al. 2015

Self Cite

View full text Add to dashboard Cite

show abstract

“…According to the Japanese clinical practice guideline for pediatric idiopathic nephrotic syndrome, kidney biopsy should be performed after 2–3 years of TAC therapy to access nephrotoxicity, even when renal dysfunction is absent . In the present series, patient 2 was the first patient to undergo kidney biopsy.…”

Section: Discussionmentioning

confidence: 86%

Prolonged tacrolimus for pediatric gastrointestinal disorder: Double‐edged sword?

Hosoi

Arai

Matsuoka

et al. 2017

Pediatrics International

Self Cite

View full text Add to dashboard Cite

show abstract

“…Zinc supplements prevent respiratory infections and reduce relapse rates in children. Ishikura et al [91] in a long term follow-up study of 46 Japanese children with frequently relapsing NS, after an initial 2-year treatment of cyclosporine (CsA), showed that half of the patients still continued to relapse frequently or were on immunosuppressive agents at the last observation (mean age 18.7 years). They postulated that there may be an association between the experience of NS relapse during cyclosporine treatment and poorer outcome at the last observation.…”

Section: Reviewmentioning

confidence: 99%

Progress in pediatrics in 2015: choices in allergy, endocrinology, gastroenterology, genetics, haematology, infectious diseases, neonatology, nephrology, neurology, nutrition, oncology and pulmonology

et al. 2016

View full text Add to dashboard Cite

This review focuses key advances in different pediatric fields that were published in Italian Journal of Pediatrics and in international journals in 2015. Weaning studies continue to show promise for preventing food allergy. New diagnostic tools are available for identifying the allergic origin of allergic-like symptoms. Advances have been reported in obesity, short stature and autoimmune endocrine disorders. New molecules are offered to reduce weight gain and insulin-resistance in obese children. Regional investigations may provide suggestions for preventing short stature. Epidemiological studies have evidenced the high incidence of Graves’ disease and Hashimoto’s thyroiditis in patients with Down syndrome. Documentation of novel risk factors for celiac disease are of use to develop strategies for prevention in the population at-risk. Diagnostic criteria for non-celiac gluten sensitivity have been reported. Negative effect on nervous system development of the supernumerary X chromosome in Klinefelter syndrome has emerged. Improvements have been made in understanding rare diseases such as Rubinstein-Taybi syndrome. Eltrombopag is an effective therapy for immune trombocytopenia. Children with sickle-cell anemia are at risk for nocturnal enuresis. Invasive diseases caused by Streptococcus pyogenes are still common despite of vaccination. No difference in frequency of antibiotic prescriptions for acute otitis media between before the publication of the national guideline and after has been found. The importance of timing of iron administration in low birth weight infants, the effect of probiotics for preventing necrotising enterocolitis and perspectives for managing jaundice and cholestasis in neonates have been highlighted. New strategies have been developed to reduce the risk for relapse in nephrotic syndrome including prednisolone during upper respiratory infection. Insights into the pathophysiology of cerebral palsy, arterial ischemic stroke and acute encephalitis may drive advances in treatment. Recommendations on breastfeeding and complementary feeding have been updated. Novel treatments for rhabdomyosarcoma should be considered for paediatric patients. Control of risk factors for bronchiolitis and administration of pavilizumab for preventing respiratory syncytial virus infection may reduce hospitalization. Identification of risk factors for hospitalization in children with wheezing can improve the management of this disease. Deletions or mutations in genes encoding proteins for surfactant function may cause diffuse lung disease.

show abstract

Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy

Cited by 79 publications

References 164 publications

Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in children

Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in children

Prolonged tacrolimus for pediatric gastrointestinal disorder: Double‐edged sword?

Progress in pediatrics in 2015: choices in allergy, endocrinology, gastroenterology, genetics, haematology, infectious diseases, neonatology, nephrology, neurology, nutrition, oncology and pulmonology

Contact Info

Product

Resources

About